| name |
Affiliation |
Title |
Topic |
| Alan Palkowitz |
Eli Lilly |
VP of Discovery Chemistry Research and Technology |
Drug Discovery on a Sea Stormy Sea: Setting a Course for Innovation |
| Joe Smith |
Johnson & Johnson |
VP of Corporate Office of Science & Technology |
Challenges and opportunities in pharmaceutical and medical device areas |
| Neil W. Gibson |
Pfizer |
Chief Scientific Officer, Oncology Research |
The discovery and development of targeted therapies in the genomic age |
| Thomas Evans |
Novartis, Shanghai |
VP/global head clinical research |
The ups and downs of antiviral research: NIM811 for HCV |
| David Nicholson |
Schering Plough Corporation, now Merck |
SVP of International drug development |
Small and Large Compounds needed!- Pharma R&D productivity |
| Michael Kafrissen |
North America Pharm CNS/IM, Johnson & Johnson OMJ |
Chief Scientific Officer |
Key steps to Phase IIIB / IV development programs |
| Grace Wong |
ActoKine Therapeutics |
CEO |
Identification of AK-1 for radioprotection and AK-2 for protection against a broad-spectrum viral infection |
| Yong Xie |
|
|
|
| Ming-Hong Hao |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Principal Scientist |
Anti-inflammatory and immune-modulating drugs -- the past, present, and future |
| Yanning Lin |
US Food and Drug Administration (FDA) |
Regulatory Review Chemist |
The Impact of USP <467> on Abbreviated New Drug Applications |
| WEIDA TONG |
FDA＊s National Center for Toxicological Research |
Director of the Center for Toxicoinformatics |
Pharmacogenomics 每 A perspective |
| Jingsong Wang |
Bristol-Myers Squibb,Co. |
Director,Discovery Medicine&Clinical Pharmacology |
Current Trends for Innovative Drug R&D-Challenges&Opportunities for China |
| Jacob Plattner |
Anacor Pharmaceuticals |
Senior Vice President, Research |
Discovery of Benzoxaboroles, a New Class of Antifungal Agents with a Novel Mechanism of Action |
| Wendy H. Chern |
Stiefel Laboratories, Inc. |
Sr.VP,Global Research and Preclinical Development |
Dermatological Product Development 每 More than skin deep |
| Stella Xu |
|
|
|
| Albert Ge |
Novartis Consumer Health |
Associate Director |
Driving Growth With New Products Through Open Innovation |
| Hong Chen |
Technology Sciences Group, Inc. |
Director, International Affairs |
cGMP 每 The Culture of the Compliance |
| Jing Xuan Kang |
Harvard University |
Professor |
Omega-3 and Health: Past, Present and Future |
| Jay Edelberg |
|
|
|
| KAWAKAMI, Koji |
Kyoto University |
Professor |
A New Era of Immunotoxins for Targeted Cancer Therapy |
